Abstract
Intrathecal (IT) drug delivery has been increasingly utilized as an analgesic option for patients with chronic refractory pain since its origins in the 1980s. Since 2000, the Polyanalgesic Consensus Conference (PACC) has developed an IT drug selection algorithm and has continually updated consensus opinions on the safety and efficacy of IT based on best evidence, literature review, and expert opinion. Although there are newer technologies that have become available for pain control, specifically spinal cord stimulation with nonparesthesia systems (high frequency and burst), intrathecal therapy is still a reliable and durable method of delivering analgesia, especially for complex and multiple areas of pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15(5):436–66.
Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Pain Physician. 2011;14:343–51.
Pope JE, Deer TR. Intrathecal pharmacology update: novel dosing strategy for intrathecal monotherapy ziconotide on efficacy and sustainability. Neuromodulation. 2015;18:414–20.
Prager J, Deer T, Levy R, et al. Best practices for intrathecal drug delivery for pain. Neuromodulation. 2014;17:354–72; discussion 372.
Rauck RL, Wallace MS, Leong MS, et al. A randomized, double-blind, placebo controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manag. 2006;31:393–406.
Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040–9.
Wallace MS, Charapata SG, Fisher R, et al. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial. Neuromodulation. 2006;9:75–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Leong, M.S., Ngai, L.K., Stuart, W.A. (2019). Intrathecal Agents and Algorithms: Review of PACC 2012 and 2017 Guidelines and Beyond. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_82
Download citation
DOI: https://doi.org/10.1007/978-3-030-12281-2_82
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12280-5
Online ISBN: 978-3-030-12281-2
eBook Packages: MedicineMedicine (R0)